Clinical Trial Update: Rituximab (RTX) for Disease Modifying Anti Rheumatic Drug (DMARD) Non-responders in Pakistan: The Pakistan Rituximab Study (PARIS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on rituximab for rheumatoid arthritis patients who are non-responsive to DMARDs in Pakistan (PARIS study); the trial status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Prof. Abid Z. Farooqi | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED